ABSTRACT
Klebsiella pneumoniae carbapenemases-producing Klebsiella pneumoniae (KPC-Kp) has caused a global public health crisis, and the severity of its infection is associated with high mortality in hospitalized patients. Therefore, the KPC-Kp prevention methods and the corresponding treatment strategy exploration are imminent. The risk factors and the treatment progress of KPC-Kp colonization or infection are reviewed in this paper to explore corresponding preventive measures and treatment strategies for clinical prevention and treatment.
ABSTRACT
OBJECTIVE:To provide reference for rational use of carbapenem antibiotics in the clinic. METHODS:Enterobac-teriaceae bacteria were collected from our hospital during Jan. 2014-Dec. 2015;semiautomatic microbiological assay instrument was used for strain culture,identification and drug sensitive tests. Modified Hodge test and K-B test were adopted to confirm Klebsiella pneumoniae carbapenemases (KPC)-producing and ESBLs-producing drug resistant strains. RESULTS:During 2014-2015,1 035 strains of Enterobacteriaceae bacteria were detected in our hospital,among which there were 732 strains of Escherichia coli,157 strains of K. pneumonia,136 strains of Enterobacter cloacae and 10 strains of Serratia marcescens. Citrobacter freundii was not found. E. coli and K. pneumonia were highly sensitive to amikacin and carbapenems,but slightly sensitive to most cephalosporin. A total of 64 strains of carbapenems-resistant Enterobacteriaceae bacteria(6.18%)were detected,among which there were 31 strains of carbapenems-resistant E. coli(4.23%),30 strains of carbapenems-resistant K. pneumonia(19.11%),1 strain of carbapenems-re-sistant E. cloacae(0.74%)and 2 strains of carbapenems-resistant S. marcescens(20.00%). The samples were mainly from sputum and urine specimens,which were mainly from neonatal department and ICU. Of 64 drug resistant strains,there were 59 KPC-pro-ducing strains (92.19%) and 3 ESBLs-producing strains (4.69%). CONCLUSIONS:E. coli occupies high proportion among En-terobacteriaceae bacteria,and the number of carbapenems-resistant E. coli and carbapenems-resistant K. pneumoniae is in high lev-el. Drug resistance of Enterobacteriaceae bacteria to carbopenems may be associated with KPC and ESBLs producing. Carbapenem antibiotics should be selected rationally in accordance with medication indications and the results of drug sensitivity test.
ABSTRACT
Objective To investigate the prevalence and transmission route of Klebsiella pneumoniae carbapenemases ( KPC)-producing Klebsiella pneumoniae in Xinhua Hospital Affiliated to Shanghaijiao Tong University School of Medicine .Methods Carbapenem-resistant Klebsiella pneumoniae isolates from clinical samples were collected from Xinhua Hospital during January 2010 and December 2013.Vitek 2 Compact and disc diffusion method ( Kirby-Bauer method ) were used for identification of the strains and antibiotic susceptibility test . Modified Hodge test was performed for drug-resistant phenotype screening . Carbapenemase gene blaKPC was amplified by PCR, and the positive products were sequenced and analyzed . Enterobacterial repetitive intergenic consensus ( ERIC )-PCR was used to analyze molecular epidemiology of the KPC-producing strains .And clinical information of these isolates was analyzed .Results There were 77 carbapenem-resistant Klebsiella pneumoniae isolates in total , and 71 of them were positive in modified Hodge test.Sixty-nine isolates were identified carrying blaKPC-2 gene.All of the KPC-2-producing isolates were classified as the same genotype by ERIC-PCR. Among 12 patients with KPC-2-producing Klebsiella pneumoniae infection who were first identified in each departments , 7 were transferred from other departments, and 4 were treated in surgery intensive care unit (SICU).Conclusions Most of carbpenem-resistant Klebsiella pneumoniae strains isolated from Xinhua Hospital are KPC-2-producing .The outbreak of carbpenem-resistant Klebsiella pneumoniae infection in the hospital may be associated with the interdepartmental transfer of patients .
ABSTRACT
A produção de carbapenemases do tipo KPC tem se tornado um importante mecanismo de resistência aos carbapenemas na família Enterobacteriaceae. Embora seja descrita predominantemente em Klebsiella pneumoniae, a enzima KPC também tem sido encontrada em diferentes espécies de Enterobacteriaceae. Contudo, pouco se sabe sobre a epidemiologia da disseminação do gene blaKPC-2 nestas outras espécies. No Brasil, a enzima KPC foi relatada inicialmente em K. pneumoniae no Recife, em 2006, mas atualmente já se encontra disseminada pelo país, onde sua incidência tem aumentado significativamente. Portanto, o objetivo desse trabalho foi realizar a caracterização molecular de amostras brasileiras produtoras de KPC pertencentes a diferentes espécies de Enterobacteriaceae (excluindo K. pneumoniae), isoladas de diferentes estados brasileiros no período de 2009 a 2011. O perfil de resistência foi avaliado por difusão em ágar e E-test. A variante alélica de blaKPC, assim como a participação do transposon Tn4401 e a análise da presença de outros genes de beta-lactamases (TEM, SHV e CTX-M) foram realizadas por PCR e sequenciamento. Análise plasmidial e hibridação foram realizadas para determinar o ambiente genético do gene blaKPC. Para a tipagem molecular foi realizado PFGE e MLST (somente para Escherichia coli)Foram encaminhadas ao Laboratório de Pesquisa em Infecção Hospitalar da Fundação Oswaldo Cruz, 83 amostras produtoras de KPC-2 (correspondendo as espécies: Enterobacter aerogenes, Enterobacter cloacae, Escherichia coli, Pantoea agglomerans, Providencia stuartii, Citrobacter freundii, Klebsiella oxytoca, Morganella morganii e Serratia marcescens) provenientes de 9 estados das regiões sudeste, nordeste e centro-oeste do país. Em amostras KPC positivas, foram encontrados altos percentuais de resistência à maioria dos antimicrobianos testados, inclusive tigeciclina (36,1 porcento não sensíveis) e polimixina B (16,5 porcento)...
The production of Klebsiella pneumoniae carbapenemase (KPC)-type enzymes has become an important mechanism of carbapenem resistance in the Family Enterobacteriaceae.Although it is predominantly described in Klebsiella pneumoniae, the KPC enzyme has also been found in different species of Enterobacteriaceae. Moreover, little is known about theepidemiology of the dissemination of blaKPC gene in other Enterobacteriaceae species. InBrazil, KPC was initially described in K. pneumoniae in Recife, state of Pernambuco, in 2006, but currently this enzyme is already disseminated throughout the country, where itsincidence has increased significantly. Thus, this study aimed to perform the molecular characterization of KPC-producing brazilian isolates belonging to different species of Enterobacteriaceae (non-K. pneumoniae) originated from different Brazilian states between2009 and 2011. The resistance profile was evaluated by disc-diffusion method and E-test. The allelic variant of the blaKPC gene, as well as the participation of Tn4401 and the presence of other beta-lactamase genes (TEM, SHV and CTX-M) were analyzed by PCR and genome sequencing. Plasmid analysis and hibridization were used to determine the genetic environment of the blaKPC gene. Molecular typing was done by PFGE and MLST (only forEscherichia coli). Eighty three unique clinical isolates of Enterobacteriaceae KPC-2-producers were referred to the Laboratório de Pesquisa em Infecção Hospitalar from Fundação Oswaldo Cruz, corresponding to 9 different species (Enterobacter aerogenes, Enterobacter cloacae, Escherichia coli, Pantoea agglomerans, Providencia stuartii, Citrobacter freundii, Klebsiella oxytoca, Morganella morganii and Serratia marcescens) isolated from 9 states located in northeast, southeast and central regions of Brazil. Highresistance rates towards most of the antimicrobial agents tested, including tigecycline (36.1 percent nonsusceptible) and polymyxin B (16.5 percent) were detected...